2009
DOI: 10.1542/peds.2008-2952l
|View full text |Cite
|
Sign up to set email alerts
|

Novel Methods of Ambulatory Physiologic Monitoring in Patients With Neuromuscular Disease

Abstract: This is a summary of the presentation on novel methods of ambulatory physiologic monitoring in patients with neuromuscular disease, presented as part of the program on pulmonary management of pediatric patients with neuromuscular disorders at the 30th annual Carrell-Krusen Neuromuscular Symposium on February 20, 2008. Pediatrics 2009123:S250-S252 R ECENTLY, CONSENSUS GUIDELINES were published for the respiratory care of patients with Duchenne muscular dystrophy and spinal muscular atrophy. These were pract… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
5
0

Year Published

2011
2011
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(5 citation statements)
references
References 11 publications
0
5
0
Order By: Relevance
“…We acknowledge that pneu RIP is a research tool and is not readily available to all clinicians; however, with further approvals (FDA), this instrument in combination with other non‐invasive pulmonary testing methods (ie, FOT) may be used to guide clinical care decisions such as respiratory support intervention and/or sleep studies. As better methods for assessment of pulmonary function are pursued, the pneu RIP could provide a more efficient, real‐time method component for patient evaluations in NM clinics as well as at home. It is noteworthy that patients with NM disease with ongoing mild‐to‐moderate respiratory muscle insufficiency appear to be using variable breathing pattern strategies to balance energy expenditure and gas exchange.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…We acknowledge that pneu RIP is a research tool and is not readily available to all clinicians; however, with further approvals (FDA), this instrument in combination with other non‐invasive pulmonary testing methods (ie, FOT) may be used to guide clinical care decisions such as respiratory support intervention and/or sleep studies. As better methods for assessment of pulmonary function are pursued, the pneu RIP could provide a more efficient, real‐time method component for patient evaluations in NM clinics as well as at home. It is noteworthy that patients with NM disease with ongoing mild‐to‐moderate respiratory muscle insufficiency appear to be using variable breathing pattern strategies to balance energy expenditure and gas exchange.…”
Section: Resultsmentioning
confidence: 99%
“…Methods used to assess breathing in NM diseases can be expensive, time consuming, and exhausting for the patients. Better methods for assessment, including in‐home evaluations, are sought . The pneu RIP could provide a more efficient method for patient pulmonary evaluation.…”
Section: Introductionmentioning
confidence: 99%
“…One evaluated breathing at home in ambulatory patients with Duchenne muscular dystrophy. 28 Another examined RIP as a possible clinical decision tool to predict admission of patients with asthma exacerbation from the emergency room. 29 Though a couple of studies have investigated quantitative use of RIP in infant sleep, only one looked at sleep in older children.…”
Section: Discussionmentioning
confidence: 99%
“…26 We did not change our standard PSG practice to include QDC; however, this may be worth considering for future studies. The advantage of our decision not to use QDC is that we were able to determine the viability of quantitative measures of TAA for PSG as previously reported 23,28,29 without change in practice or additional cost or effort.…”
Section: Discussionmentioning
confidence: 99%
“…RIP was implemented by integrating RIP belts in wearable garments in a 2007 study to assess the effect of adherence of RIP belts to the human body [72]. RIP has demonstrated its ability to be used for long-term monitoring purposes, i.e., in patients with neuromuscular disease [73].…”
Section: Evolution Of Ripmentioning
confidence: 99%